A new study published in the journal Psychedelics reveals that the environment and physiological state of an animal ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

Explore how psilocybin affects social behaviour and inflammation in female mice in groundbreaking research at Monash ...

Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...

Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

Richard Schaefer took part in a clinical trial of psilocybin as a treatment for addiction. (Photo courtesy of Richard Schaefer) It was a day like any other when Richard Schaefer entered a Madison ...

PORTLAND, Ore. — For the first time, a scientific study has examined Oregon's pioneering model for psilocybin therapy, reflecting on a program now two years underway. Psilocybin is the psychedelic ...

Use of psilocybin, the hallucinogenic chemical found in what is known as "magic mushrooms," has increased significantly nationwide since 2019, according to a new study led by researchers at the ...

Bend-based Bendable Therapy, a psilocybin treatment facility, paired with Osmind, a psychiatry through technology company, to study the effects of psilocybin on depression and anxiety. The study ...

An ongoing study, conducted by Erin Mauney, MD, is taking a fascinating new approach to this mysterious condition: psychedelics, and more specifically psilocybin. In this article, we will investigate ...